Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG vs Mannitol for CT Enterography
NCT03495804Unknown
- Sponsor
- Shandong University
- Start
- Nov 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of polyethylene glycol 3350 + bisacodyl in Small bowel disorders and inflammatory bowel disease (IBD) (2 arms), sponsored by Shandong University. Primary endpoint: Performance of two neutral oral contrast agents in CT enterography at 12 months. Status: unknown.
02
Drugs
polyethylene glycol 3350 + bisacodyl
03
Conditions
Small bowel disordersinflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NCT03495804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03495804.